|
| Exchange Disseminated Time 22/11/2016 19:08:18 | | Sun Pharmaceutical Industries Ltd has informed BSE that the Company have received a letter intimating to the Company from the Company's Chief Financial Officer (CFO), Mr. Uday Baldota that he would be tendering his resignation as the CFO of Sun Pharmaceutical Industries Limited to be effective with effect from in and around April, 2017 due to his shifting to United States of America in and around April, 2017 to look after the business of Taro Pharmaceutical Industries Ltd, a subsidiary of Sun Pharmaceutical Industries Limited as its Chief Executive Officer. |
|
|